Clinical efficacy of short-term treatment with extra-fine HFA beclomethasone diproprionate in patients with post-infectious persistent cough

Journal of Physiology and Pharmacology

Volumn 58, Issue SUPPL. 5, 2007, Pages 223-232

  Gillissen, A ^a   Richter, A ^b   Oster, H ^b  

^a Robert Koch Klinik   (Germany)

^b Astellas Pharma GmbH   (Germany)

Author keywords

Beclomethasone dipropionate; Inhaled corticosteroid; Post infectious cough; Tussometry

Indexed keywords

BECLOMETASONE DIPROPIONATE; FORMOTEROL; PLACEBO;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DOSAGE SCHEDULE COMPARISON; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; INFECTION COMPLICATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; TREATMENT DURATION;

ACUTE DISEASE; ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ADULT; AEROSOL PROPELLANTS; ANTITUSSIVE AGENTS; BECLOMETHASONE; CHEMISTRY, PHARMACEUTICAL; COUGH; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; GERMANY; HUMANS; HYDROCARBONS, FLUORINATED; MALE; MIDDLE AGED; PATIENT COMPLIANCE; POWDERS; RESPIRATORY TRACT INFECTIONS; TREATMENT OUTCOME;

EID: 40449136275     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Braman SS. Chronic dough due to acute bronchitis: ACCP evidence-based clinical practice guidelines. Chest 2006; 129:95S-103S.
2. Widdicombe JG. Advances in understanding and treatment of cough. Monaldi Arch Chest Dis 1999; 54:275-279.
3. Holinger LD, Sanders AD. Chronic cough in infants and children: an update. Laryngoscope 1991; 101:596-605.
4. Lee PC, Cotterill-Jones C, Eccles R. Voluntary control of cough. Pulm Phamacol Therapeutics 2002; 15:317-320.
5. McCool FD. Global physiology and pathophysiology of cough: ACCP evidence-based clinical practice guidelines. Chest 2006; 129:48S-53S.
6. Hutchings HA, Eccles R, Smith AP, Jawad M. Voluntary cough suppression an indication of symptom severity in upper respiratory tract infections. Eur Respir J 1993; 6:1449-1454.
7. Jordan D. Central nervous mechanisms in cough. Pulm Pharmacol 1996; 9:389-392.
8. Palombini BC, Villanova CA, Araujo E et al. A pathogenic triad in chronic cough: asthma, postnasal drip syndrome, and gastroesophageal reflux disease. Chest 1999; 116:279-284.
9. Marchesani F, Cecarini L, Pela R, Sanguinetti CM. Causes of chronic persistent cough in adult patients: the results of a systematic management protocol. Monaldi Arch Chest Dis 1998; 53:510-514.
10. Rosen MJ. Chronic cough due to bronchiectasis: ACCP evidence-based clinical practice guidelines. Chest 2006; 129:122S-131S.
11. MacRedmond R, O'Connell F. Treatment of persistent dry cough: if possible, treat the cause; if not, treat the cough. Monaldi Arch Chest Dis 1999; 54:269-274.
12. Kardos P, Cegla U, Gillissen A et al. Leitlinie der Deutschen Gesellschaft für Pneumologie zur Diagnostik und Therapie von Patienten mit akutem und chronischem Husten. Pneumologie 2004; 99:468-475.
13. Braman SS. Postinfectious cough: ACCP evidence-based clinical practice guidelines. Chest 2006; 129:138S-146S.
14. Shimizu T, Mochizuki H, Morikawa A. Effect of influenza A virus infection on acid-induced cough response in children with asthma. Eur Respir J 1997; 10:71-74.
15. Cho YS, Park SY, Lee CK et al. Enhanced cough response to hyperpnea with cold air challenge in chronic cough patients showing increased cough sensitivity to inhaled capsaicin. Allergy 2003; 58:486-491.
16. French CL, Irwin RS, Curley FJ, Krikorian CJ. Impact of chronic cough on quality of life. Arch Int Med 1998; 158:1657-1661.
17. Chaudhuri R, McMahon AD, Thomson LJ et al. Effect of inhaled corticosteroids on symptom severity and sputum mediator levels in chronic persistent cough. J Allergy Clin Immunol 2004; 113:1063-1070.
18. Leach CL, Davidson PJ, Boudreau RJ. Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone. Eur Respir J 1998; 12:1346-1353.
19. Worth H, Murr JF, Pieters WR. Comparison of hydrofluoroalkane- beclomethasone dipropionate autohaler™ with budesonide turbuhaler™ in asthma control. Respiration 2001; 68:517-526.
20. Busse WW, Brazinsky S, Jacobson K et al. Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant. J Allergy Clin Immunol 1999; 104:1215-1222.
21. -1) in patients with asthma. Respir Med 2001; 95:212-220.
22. Irwin RS, Ownbey R, Cagle PT, Baker S, Fraire AE. Interpreting the histopathology of chronic cough: a prospective, controlled, comparative study. Chest 2006; 130:362-370.
23. Jatakanon A, Lalloo UG, Lim S, Chung KF, Barnes PJ. Increased neutrophils and cytokines, TNF-alpha and IL-8, in induced sputum of non-asthmatic patients with chronic dry cough. Thorax 1999; 54:234-237.
24. Heino M, Juntunen-Backman K, Leijala M, Rapola J, Laitinen LA. Bronchial epithelial inflammation in children with chronic cough after early lower respiratory tract illness. Am Rev Respir Dis 1990; 141:428-432.
25. Pizzichini MM, Pizzichini E, Parameswaran K et al. Nonasthmatic chronic cough: No effect of treatment with an inhaled corticosteroid in patients without sputum eosinophilia. Can Respir J 1999; 6:323-330.
26. Pornsuriyasak P, Charoenpan P, Vongvivat K, Thakkinstian A. Inhaled corticosteroid for persistent cough following upper respiratory tract infection. Respirology 2005; 10:520-524.
27. Lee PCL, Jawad MS, Eccles R. Antitussive efficacy of dextromethorphan in cough associated with upper respiratory tract infection. J Pharm Pharmacol 2000; 52:1137-1142.
28. Eccles R, Morris S, Jawad M. Lack of effect of codeine in the treatment of cough associated with acute upper respiratory tract infection. J Clin Pharm Ther 1992; 17:175-180.
29. Eccles R. The powerful placebo in cough studies? Pulm Phamacol Therapeutics 2002; 15:303-308.